BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190927
DTSTAMP:20260430T065711
CREATED:20190904T152040Z
LAST-MODIFIED:20190919T112809Z
UID:20064-1569283200-1569542399@senzagen.com
SUMMARY:8th Annual Meeting of the ASCCT
DESCRIPTION:Computational Toxicology: Peeking into the Clouds while Keeping our Feet on Solid Ground \nThursday\, September 26\n9:50: Session III\nThe GARD platform: Cutting-edge technology using genomics and machine learning to test for various toxicological endpoints (Schmidt\, Senzagen)
URL:https://senzagen.com/event/8th-annual-meeting-of-the-ascct/
LOCATION:Gaithersburg\, Md\, USA
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/ascct-logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190919
DTSTAMP:20260430T065711
CREATED:20190903T122804Z
LAST-MODIFIED:20190917T105358Z
UID:20037-1568764800-1568851199@senzagen.com
SUMMARY:North American Biocompatibility Summit (NABS)
DESCRIPTION:(NABS)\, a limited-seating event that will provide industry insights and expertise sharing on the biocompatibility of medical devices\, including the latest regulatory updates\, biological evaluation strategies and best practices that lead to successful biocompatibility programs. \nSessions will be led by the medical device industry’s foremost biological safety experts.
URL:https://senzagen.com/event/north-american-biocompatibility-summit-nabs/
LOCATION:Minneapolis\, USA
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/nabs-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190908
DTEND;VALUE=DATE:20190912
DTSTAMP:20260430T065711
CREATED:20190520T115547Z
LAST-MODIFIED:20190904T070917Z
UID:19586-1567900800-1568246399@senzagen.com
SUMMARY:EUROTOX 2019
DESCRIPTION:Will you be at Eurotox in Helsinki in September? We are looking forward to meeting you and to share the latest news about the GARD assay platform development. \nAt the conference\, we will launch GARD®skin Medical Device for biocompatibility assessment of medical devices. Our expert Dr Rose-Marie Jenvert will attend and present a poster during the session on Monday 9 Sept. Read more or book a meeting with her to learn more about this exciting new assay! \nWe will also present our latest data on solvent selection at the same poster session. Dr Olivia Larne will be available to answer your questions.\n\nMeet our team at our booth #36! \nView our posters\n \nID 482 | Viewing 1 | Board no P06-054 | Monday\, Sept 9 from 09:00\nIn vitro skin sensitization testing of Medical Devices using GARD® \nID 835 | Viewing 1 | Board number P-06-100 | Monday\, Sept 9 from 09:00\nExtended solvent selection for in vitro sensitization testing using GARD®
URL:https://senzagen.com/event/eurotox-2019/
LOCATION:Helsinki\, Finland\, Helsinki\, Finland
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/05/eurotox19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190905
DTEND;VALUE=DATE:20190907
DTSTAMP:20260430T065711
CREATED:20190904T074157Z
LAST-MODIFIED:20190904T074240Z
UID:20048-1567641600-1567814399@senzagen.com
SUMMARY:The 29th Annual BioInterface Workshop & Symposium
DESCRIPTION:
URL:https://senzagen.com/event/the-29th-annual-biointerface-workshop-symposium-2/
LOCATION:Park City\, USA\, UT\, United States
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/biointerface-2019-b-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190715
DTEND;VALUE=DATE:20190719
DTSTAMP:20260430T065711
CREATED:20190520T094342Z
LAST-MODIFIED:20190520T095110Z
UID:19562-1563148800-1563494399@senzagen.com
SUMMARY:IUTOX – The 15th International Congress Of Toxicology
DESCRIPTION:IUTOX and the Society of Toxicology\, USA (SOT) are pleased to announce the next triennial International Congress of Toxicology (ICT) to be held July 15–18\, 2019\, at the Hawaii Convention Center in Honolulu\, Hawaii\, USA—a forum for scientists in academia\, government\, and industry from around the world to learn about the latest developments in toxicological science and regulation.
URL:https://senzagen.com/event/iutox/
LOCATION:Honolulu\, Hawaii\, Honolulu\, HI\, United States
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/05/IUTOX-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190612T110000
DTEND;TZID=America/New_York:20190612T120000
DTSTAMP:20260430T065711
CREATED:20190524T090118Z
LAST-MODIFIED:20190524T090507Z
UID:19611-1560337200-1560340800@senzagen.com
SUMMARY:ASCCT & ESTIV GARDair Webinar
DESCRIPTION:GARD™air – An in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning \nPresenter: Joshua Schmidt\, SenzaGen Inc.\, USA\nCo-author: Andy Forreryd\, SenzaGen AB\, Lund\, Sweden \nRegistration link: https://attendee.gotowebinar.com/register/2480462347058889485
URL:https://senzagen.com/event/ascct-estiv-gardair-webinar/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/05/ASCCT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190612
DTEND;VALUE=DATE:20190614
DTSTAMP:20260430T065711
CREATED:20190308T123912Z
LAST-MODIFIED:20190520T095659Z
UID:18852-1560297600-1560470399@senzagen.com
SUMMARY:NVT Annual Meeting\, Dutch Society of Toxicology
DESCRIPTION:Presentation by Dr. Andy Forreryd \nSession: Developing in vitro based alternatives to animal testing\nDate: 13 June\nTime: 14:00-15:30\nChair: Prof. Juliette Legler\nSpeakers: Dr. Ivan Kopljar\, Dr. Peter Racz\, Dr. Andy Forreryd \nThe 40th NVT annual meeting will be all about innovation through integration. We will be looking to identify the gaps between academia\, industry and regulatory\, between different academic fields\, and within academic fields. Once we know the gaps\, we can build the bridges that are needed for better integration and better science. The meeting’s programme will be developed in collaboration with all of the NVT sections. \n  \n 
URL:https://senzagen.com/event/nvt-annual-meeting-dutch-society-of-toxicology/
LOCATION:Ede\, Netherlands\, Ede\, Netherlands
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/03/Small-NVT-Toxicology-text-leaf.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190418T140000
DTEND;TZID=America/New_York:20190418T150000
DTSTAMP:20260430T065711
CREATED:20190308T123043Z
LAST-MODIFIED:20190308T124943Z
UID:18848-1555596000-1555599600@senzagen.com
SUMMARY:Free Webinar: Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro sensitization testing (US)
DESCRIPTION:AMERICAN TIMEZONE  2 am EDT \nAre you curious about potential applications of genomics or machine learning?  Have you ever wondered how the GARD test platform works?  This presentation will provide a comprehensive explanation on how genomics and machine learning have been combined to create the GARD test platform for in vitro testing of respiratory and skin sensitizers.  This will include an in-depth explanation of this unique technology\, how it works\, and why it is highly accurate and has such robust prediction.   \nThis presentation will include discussions on: \n\nThe background of the genomic-based GARD™ test with an accuracy over 90% and how it compares and combines with other in vivo and in vitro sensitization assays\nComprehensive description of the GARD algorithm and how the technology actually works\n\nGenomics as a tool for analysis of immunotoxicological responses\nMethod development steps beginning with screening the entire human genome on array platforms for relevant biomarkers to a streamlining the analytical model. This will include the benefits of a data driven approach in test development providing a holistic view of the immunological response.\nA short introduction and explanation of the prediction model and how machine learning algorithms are applied for classifying results. What does the model do? Does it change? How can pattern recognition models be applied to biological gene expression data?\n\n\nOne platform enabling several tests – How is this possible?\nSimple to use\, easy and transparent classifications\, no expert judgements required\nApplicability of the GARD™platform – What chemicals can I test in GARD? How can this in vitro test analyse “difficult to test substances”\, mixtures\, pre-pro haptens\, UVCBs\, etc? Including GARD test cases and what types of chemicals have been tested already.\nWhere can I get my testing done?\n\n  \nWhat should I know before the webinar?\nNo previous knowledge about GARD is required. No technical background on genomics\, machine learning algorithms\, or programming required. No bioinformatics or immunological expertise required. \n  \nWho should attend?   \n\nAnyone interested in the GARD technology.\nRegulators\, policymakers\, or CROs who want to understand more about the technology.\nSafety Assessors\, Responsible Persons\, Product Development managers and testers\, Product Safety managers and assistants\, Lab personnel\, and anyone concerned with assessing product safety or toxicology.\nAnyone interested in learning about genomics and next generation animal-free test development for hazard assessments\n\nFor registration KLICK HERE
URL:https://senzagen.com/event/genomics-and-machine-learning-all-you-need-to-know-about-the-gard-technology-for-in-vitro-sensitization-testing-2/
LOCATION:GoToWebinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20190417T110000
DTEND;TZID=Europe/Stockholm:20190417T120000
DTSTAMP:20260430T065711
CREATED:20190308T121723Z
LAST-MODIFIED:20190308T125007Z
UID:18838-1555498800-1555502400@senzagen.com
SUMMARY:Free webinar: Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro sensitization testing (EUR)
DESCRIPTION:EUROPEAN TIMEZONE \nAre you curious about potential applications of genomics or machine learning?  Have you ever wondered how the GARD test platform works?  This presentation will provide a comprehensive explanation on how genomics and machine learning have been combined to create the GARD test platform for in vitro testing of respiratory and skin sensitizers.  This will include an in-depth explanation of this unique technology\, how it works\, and why it is highly accurate and has such robust prediction.   \nThis presentation will include discussions on \n\nThe background of the genomic-based GARD™ test with an accuracy over 90% and how it compares and combines with other in vivo and in vitro sensitization assays\nComprehensive description of the GARD algorithm and how the technology actually works\n\nGenomics as a tool for analysis of immunotoxicological responses\nMethod development steps beginning with screening the entire human genome on array platforms for relevant biomarkers to a streamlining the analytical model. This will include the benefits of a data driven approach in test development providing a holistic view of the immunological response.\nA short introduction and explanation of the prediction model and how machine learning algorithms are applied for classifying results. What does the model do? Does it change? How can pattern recognition models be applied to biological gene expression data?\n\n\nOne platform enabling several tests – How is this possible?\nSimple to use\, easy and transparent classifications\, no expert judgements required\nApplicability of the GARD™platform – What chemicals can I test in GARD? How can this in vitro test analyse “difficult to test substances”\, mixtures\, pre-pro haptens\, UVCBs\, etc? Including GARD test cases and what types of chemicals have been tested already.\nWhere can I get my testing done?\n\n  \nWhat should I know before the webinar?\nNo previous knowledge about GARD is required. No technical background on genomics\, machine learning algorithms\, or programming required. No bioinformatics or immunological expertise required. \n  \nWho should attend?   \n\nAnyone interested in the GARD technology.\nRegulators\, policymakers\, or CROs who want to understand more about the technology.\nSafety Assessors\, Responsible Persons\, Product Development managers and testers\, Product Safety managers and assistants\, Lab personnel\, and anyone concerned with assessing product safety or toxicology.\nAnyone interested in learning about genomics and next generation animal-free test development for hazard assessments.\n\nFor registration KLICK HERE  \n 
URL:https://senzagen.com/event/genomics-and-machine-learning-all-you-need-to-know-about-the-gard-technology-for-in-vitro-sensitization-testing/
LOCATION:GoToWebinar
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190402
DTEND;VALUE=DATE:20190405
DTSTAMP:20260430T065711
CREATED:20190308T124609Z
LAST-MODIFIED:20190325T133250Z
UID:18859-1554163200-1554422399@senzagen.com
SUMMARY:in-cosmetics global
DESCRIPTION:Heading into its 30th edition in 2019\, in-cosmetics Global is the leading event for personal care ingredients. The exhibition brings together personal care ingredients suppliers (exhibitors) with finished product manufacturers (visitors)\, each looking to network\, learn about future trends\, and discover new products. \nSenzaGen will participate and attend workshops
URL:https://senzagen.com/event/in-cosmetics-global/
LOCATION:Paris\, France
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/03/in-cosmetics-Global.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20190310T080000
DTEND;TZID=Europe/Stockholm:20190314T170000
DTSTAMP:20260430T065711
CREATED:20190129T084031Z
LAST-MODIFIED:20190311T174040Z
UID:18585-1552204800-1552582800@senzagen.com
SUMMARY:SOT 58th Annual Meeting and ToxExpo
DESCRIPTION:SenzaGen will exhibit at Booth #3652  \nShare your knowledge at the largest toxicology meeting in the world and get the latest updates on the advances in toxicology by attending the SOT 58 Annual Meeting and ToxExpo\, in Baltimore\, Maryland\, USA. \nSenzaGen poster sessions at CC Exhibit Hall\, further details below: \nTitle: A Novel 68-Gene Biomarker Signature to Identify Respiratory Irritation/Toxicity Induced by Inhaled Compounds – Using Machine-Learning Assisted Classifications Based on Transcriptomic Data from Calu-3 Cells. \nAbstract Number: 1437\nPoster Board number: P503\nPresentation Date: March 11\, at 2019 9:15:00 AM to 4:30:00 PM \nTitle: Extended Applicability Domain for GARD with Vehicles for Medical Device\nAbstract Number: 2948\nPoster Board number: P382\nPresentation Date: March 13\, 2019 at 9:15:00 AM to 4:30:00 PM \n \n 
URL:https://senzagen.com/event/sot-58th-annual-meeting-and-toxexpo/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/01/SOT-AM19-Email-Banner1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190207T120000
DTEND;TZID=Europe/Helsinki:20190208T120000
DTSTAMP:20260430T065711
CREATED:20190115T132257Z
LAST-MODIFIED:20190115T133053Z
UID:18573-1549540800-1549627200@senzagen.com
SUMMARY:Joint EPAA/ Cefic-LRI / IFRA Europe Training and Knowledge-sharing workshop 2019
DESCRIPTION:SenzaGen is attending the Training and Knowledge-sharing Workshop – “Applying non-animal strategies for assessing skin sensitization” in Helsinki\, Finland. \nThe main objective of the workshop is to discuss how the information produced from non-animal assays for skin sensitisation can be used in regulatory decision-making for hazard identification (classification & labelling) but also for risk assessment decisions\, i.e. by taking potency into account. \n  \n  \n 
URL:https://senzagen.com/event/joint-epaa-cefic-lri-ifra-europe-training-and-knowledge-sharing-workshop-2019/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/01/Helsinki_2019_-joint-event_feb.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181210
DTEND;VALUE=DATE:20181213
DTSTAMP:20260430T065711
CREATED:20181029T111645Z
LAST-MODIFIED:20181029T172652Z
UID:18070-1544400000-1544659199@senzagen.com
SUMMARY:The Society of Toxicology of Canada 50th Annual Symposium\, Winter 2018
DESCRIPTION:SenzaGen is participating at \nThe Society of Toxicology of Canada 50th Annual Symposium\, Winter 2018\nWHAT’S IN A NAM ?  (NOVEL APPROACH METHODOLOGIES). \nBENEFITS\, LIMITATIONS\, TRANSLATION\, COMMUNICATION. \n| DECEMBER 10 TO 12\, 2018 |\n| VENUE:  COURTYARD BY MARRIOTT – TORONTO | \nThe Society of Toxicology of Canada Inc. is a non-profit association whose objectives are to promote the acquisition\, facilitate the dissemination\, and encourage the utilization of knowledge in the science of toxicology. \nThe STC supports continuing education and excellence in research through its Annual Symposium\, which provides a venue for members and international experts to present the latest advances in experimental and regulatory toxicology. \nThe Society recognizes the universality of science and adheres to principles which affirm membership and free circulation of bona fide scientists in a non-discriminatory fashion.
URL:https://senzagen.com/event/the-society-of-toxicology-of-canada-50th-annual-symposium-winter-2018/
LOCATION:COURTYARD BY MARRIOTT – TORONTO DOWNTOWN
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/10/toronto-city.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181205T130000
DTEND;TZID=America/New_York:20181205T140000
DTSTAMP:20260430T065711
CREATED:20181105T160248Z
LAST-MODIFIED:20181106T104647Z
UID:18240-1544014800-1544018400@senzagen.com
SUMMARY:Open Webinar on Respiratory Sensitization by SenzaGen
DESCRIPTION:In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform \nA seminar given on two occasion. This one targeted forthe US audience at 13:00 EST  (19:00 CET) \nThe presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  A thorough explanation of the GARD™ platform will be covered as well as its versatility and reliability for safety assessment applicable to all industries. Sensitization testing with GARD™ is based on functional genomics. \nThe presentation will cover: \n\nDevelopment of the genomic-based GARD™ test platform for skin sensitization hazard\, potency classification\, and now also respiratory sensitization.\nDendritic cells – why they are also relevant for respiratory sensitization.\nGene mapping – what genes are in the assay\, and how are they relevant for sensitization.\nHow GARD™ can discriminate between skin and respiratory sensitization and why this is relevant.\nUpdate on the development of the SenzaGen R&D pipeline including GARD™ for materials – testing medical devices\, GARD™ for proteins – classification of protein sensitizers\, GARD™ for mixtures – assessment of complex formulations and Unknown or Variable Composition UVCBs.\n\n  \nNext generation in vitro skin and respiratory sensitization testing using genomics with GARD™ \nThe GARD™ platform is a versatile in vitro testing strategy which currently consist of three assays targeting two toxicological endpoints: skin sensitization (GARDskin & GARDpotency) and respiratory sensitization (GARDair). These assays make use of unique genomic biomarker signatures comprising genes involved in pathways known to be immunologically relevant to the sensitization process. Supported by modern technologies for pattern recognition\, the large informational content provided by this approach enable for mechanism-of-action based decisions\, which becomes evident in a consistently high predictive accuracy \n\nDon’t miss the opportunity to learn more from our researchers. Welocome to join! \nREGISTER HERE \n  \n 
URL:https://senzagen.com/event/open-webinar-on-respiratory-sensitization-by-senzagen-2/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20181204T150000
DTEND;TZID=Europe/Stockholm:20181204T160000
DTSTAMP:20260430T065711
CREATED:20181105T160230Z
LAST-MODIFIED:20181106T104722Z
UID:18231-1543935600-1543939200@senzagen.com
SUMMARY:Open Webinar on Respiratory Sensitization by SenzaGen
DESCRIPTION:In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform \nA seminar given on two occasions\, this one targeted for the EUROPEAN time zone \nThe presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  A thorough explanation of the GARD™ platform will be covered as well as its versatility and reliability for safety assessment applicable to all industries. Sensitization testing with GARD™ is based on functional genomics. \nThe presentation will cover: \n\nDevelopment of the genomic-based GARD™ test platform for skin sensitization hazard\, potency classification\, and now also respiratory sensitization.\nDendritic cells – why they are also relevant for respiratory sensitization.\nGene mapping – what genes are in the assay\, and how are they relevant for sensitization.\nHow GARD™ can discriminate between skin and respiratory sensitization and why this is relevant.\n\nUpdate on the development of the SenzaGen R&D pipeline including GARD™ for materials – testing medical devices\, GARD™ for proteins – classification of protein sensitizers\, GARD™ for mixtures – assessment of complex formulations and Unknown or Variable Composition UVCBs. \n  \nNext generation in vitro skin and respiratory sensitization testing using genomics with GARD™\nThe GARD™ platform is a versatile in vitro testing strategy which currently consist of three assays targeting two toxicological endpoints: skin sensitization (GARDskin & GARDpotency) and respiratory sensitization (GARDair). These assays make use of unique genomic biomarker signatures comprising genes involved in pathways known to be immunologically relevant to the sensitization process. Supported by modern technologies for pattern recognition\, the large informational content provided by this approach enable for mechanism-of-action based decisions\, which becomes evident in a consistently high predictive accuracy. \nDon’t miss the opportunity to learn more from our researchers. Welcome to join! \nREGISTER HERE
URL:https://senzagen.com/event/open-webinar-on-respiratory-sensitization-by-senzagen/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20181129T080000
DTEND;TZID=Europe/Stockholm:20181129T170000
DTSTAMP:20260430T065711
CREATED:20181029T130514Z
LAST-MODIFIED:20181029T151616Z
UID:18108-1543478400-1543510800@senzagen.com
SUMMARY:EUROFINS Human Safety Seminar - in vitro Toxicology at a Glance. Today's Challenges\, Solutions & Future Developments
DESCRIPTION:Dr Andy Forreryd is one of three speakers at the Human Safety Seminar organised by Eurofins BioPharma Product Testing Munich where he is to present the GARD platform for skin and respiratory sensitization  \nTopics for the seminar:  \n\nIn vitro Methods to test for Endocrine Disrupting Properties  \nIn vitro Skin sensitization – Challenges to Overcome \nEye Irritation ex vivo and in vitro methods – Current status \nGARD platform\, genomic test for skin and respiratory sensitization with potency classification  \nNew Developments in Genotoxicity Testing for Chemicals\, Cosmetics and Pharmaceuticals – in vitro and in vivo Comet Assay \n\nFor more information and registration  \nhttps://www.eurofins.com/human-safety-seminar
URL:https://senzagen.com/event/eurofins-human-safety-seminar-in-vitro-toxicology-at-a-glance-todays-challenges-solutions-future-developments/
LOCATION:Eurofins Munich\, Robert-Koch-Straße 3a\, Planegg
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/10/save-the-date_final_web.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181129
DTSTAMP:20260430T065711
CREATED:20181029T144439Z
LAST-MODIFIED:20181031T092502Z
UID:18057-1543276800-1543449599@senzagen.com
SUMMARY:SFT - Société Francaise de Toxicologie
DESCRIPTION:En 2018\, le congrès annuel de la SFT a lieu à Lille\, les 27 et 28 novembre\, espace Jeanne de Flandre (Lille Grand Palais). \nPoster\nGARD® – in vitro safety assessment of skin and respiratory sensitizers using a genomics-based platform \nMeet Anna Cherouvrier Hansson at the conference. To book a meeting\, please email: anna.c.hansson (at) senzagen.com
URL:https://senzagen.com/event/sft-societe-francaise-de-toxicologie/
LOCATION:Lille Grand Palais\, France
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/10/logo_sft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181127
DTEND;VALUE=DATE:20181130
DTSTAMP:20260430T065711
CREATED:20180911T085055Z
LAST-MODIFIED:20181102T123937Z
UID:17541-1543276800-1543535999@senzagen.com
SUMMARY:Biocompatibility for Medical Devices\, Barcelona\, Spain
DESCRIPTION:SenzaGen is participating at the Biocompatibility for Medical Devices\, Barcelona. \nUpdates and changes to the ISO 10993 standards\, regulatory updates and case studies of how to use ISO 10993 for evaluation of Medical Devices\nISO 10993: ARE YOU BIOCOMPATIBLE?\nRisk Mitigation. Chemical Characterisation. Practical Implementation. \n  \nMeet our Medical Device experts Rose-Marie Jenvert and Joshua Schmidt  at the conference! \nTo book a meeting\, please email them\nrose-marie.jenvert (a) senzagen.com\njoshua.schmidt (a) senzagen.com
URL:https://senzagen.com/event/biocompatibility-for-medical-devices-barcelona-spain/
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/05/Biocompatibility-for-Medical-Devices-logo-COLOR-5ba41af89b878f0aae531e1751febc8a.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181105
DTEND;VALUE=DATE:20181108
DTSTAMP:20260430T065711
CREATED:20180911T084622Z
LAST-MODIFIED:20180911T084634Z
UID:17535-1541376000-1541635199@senzagen.com
SUMMARY:Bio Europe\, Copenhagen\, Denmark
DESCRIPTION:24th annual conference
URL:https://senzagen.com/event/bio-europe-copenhagen-denmark/
LOCATION:Copenhagen\, Denmark
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/05/BEU18-Logos-NEW-05-999add75136ab900b4a4c046561f6920.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181104
DTEND;VALUE=DATE:20181108
DTSTAMP:20260430T065711
CREATED:20181029T172737Z
LAST-MODIFIED:20181029T172737Z
UID:18092-1541289600-1541635199@senzagen.com
SUMMARY:ACT 2018 – American College of Toxicology Annual Meeting
DESCRIPTION:SenzaGen is participating at The American College of Toxicology 2018 Annual Meeting that will be held Nov. 4-7 in West Palm Beach. \nThis year’s meeting will feature lectures\, poster sessions\, and other events for today’s toxicologists to network with each other and hone their skills. \nFor more information on ACT 2018\, please visit www.actox.org.
URL:https://senzagen.com/event/act-2018-american-college-of-toxicology-annual-meeting/
LOCATION:Palm Beach County Convention Center
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/10/ACT-hp-slider4inner2f.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181031
DTEND;VALUE=DATE:20181102
DTSTAMP:20260430T065711
CREATED:20181029T150050Z
LAST-MODIFIED:20181031T091912Z
UID:18119-1540944000-1541116799@senzagen.com
SUMMARY:Medical Design & Manufacturing (MD&M) Minneapolis
DESCRIPTION:SenzaGen is present at the\nMedical Design & Manufacturing (MD&M) Minneapolis \nThe MD&M Minneapolis Conference is the region’s largest educational offering of its kind\, taking place in North America’s second largest hub for medical device innovation — the Midwest. This year’s conference lineup features a curated roster of speakers with deeply technical expertise in everything from product development and quality to 3D printing and next-gen design. \nMedical Design & Manufacturing (MD&M) Minneapolis is where serious professionals find the technologies\, education\, and connections needed to thrive in the medtech community. \nMeet SenzaGen Business Development Director\, Joshua Schmidt at MD&M.\nTo book a meeting\, please email:  joshua.schmidt (at) senzagen.com
URL:https://senzagen.com/event/medical-design-manufacturing-mdm-minneapolis/
LOCATION:Minneapolis Convention Center\, United States
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/10/mdm_logo_0.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181015
DTEND;VALUE=DATE:20181019
DTSTAMP:20260430T065711
CREATED:20180911T084441Z
LAST-MODIFIED:20180918T211345Z
UID:17531-1539561600-1539907199@senzagen.com
SUMMARY:ESTIV 2018\, 20th International Congress on In Vitro Toxicology\, Berlin
DESCRIPTION:SenzaGen is proud to sponsor\, exhibit and present poster at the ESTIV conference\, 2018.\n\nThe conference emphasis will be specifically on how new technologies can strengthen the interpretation and application of in vitro methods in toxicological research and risk assessment. \nThe ESTIV conference will be the official launch of the new GARDair\, the first in vitro test for airway allergies. \nFind us in Booth #19\nPoster: GARDair – A novel assay for assessment of chemical respiratory sensitizers based on a genomic platform
URL:https://senzagen.com/event/20th-international-congress-on-in-vitro-toxicology-berlin-senzagen-is-proud-to-sponsor-exhibit-and-present-poster-at-the-estiv-conference-2018/
LOCATION:Berlin\, Germany
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/09/ESTIV_2018_Web_300x250px_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181003
DTEND;VALUE=DATE:20181005
DTSTAMP:20260430T065711
CREATED:20180911T083913Z
LAST-MODIFIED:20180911T084923Z
UID:17527-1538524800-1538697599@senzagen.com
SUMMARY:The 7th Medicon Valley Inhalation Symposium – Future Opportunities of Inhalation 2018
DESCRIPTION:SenzaGen is proud to sponsor\, exhibit and present at MVIC’s Symposium\, MVIS\, 2018 \nDate: Wednesday the 3rd of October – Thursday the 4th of October 2018\nTime: Day 1: 09.00–18.00. Day 2: 09.00–13.00\nPlace: Medicon Village\, Lund\, Sweden \nPresentation\, Day 2: 09.25–09.50 \, Predictive Respiratory Toxicology with the GARD In-Vitro Testing Platform\, Dr Henrik Johansson\, SenzaGen AB
URL:https://senzagen.com/event/the-7th-medicon-valley-inhalation-symposium-future-opportunities-of-inhalation-2018/
LOCATION:Medicon Village\, Scheelevägen 2\, Lund\, Sweden
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/09/MVIC_symposium.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181002
DTEND;VALUE=DATE:20181003
DTSTAMP:20260430T065711
CREATED:20180911T083515Z
LAST-MODIFIED:20180911T085550Z
UID:17522-1538438400-1538524799@senzagen.com
SUMMARY:Understanding Biocompatibility of Medical Devices\, Medicon Village\, Lund
DESCRIPTION:SenzaGen are the hosts of this  Medicon Valley MedTech Network meeting. \nThe regulatory framework of the medical device industry is going through major changes and the complexity of the process is increasing due to new requirements and standards. All medical devices that come into physical contact with patients must be assessed for allergy. Therefore\, manufacturers must conduct biological safety evaluations before market approval. \nWelcome to join us at the next Medicon Valley MedTech Network meeting to learn more about ISO 10993* and the recent changes in the standard\, and understand how to make a biological evaluation of your medical device products.
URL:https://senzagen.com/event/understanding-biocompatibility-of-medical-devices-medicon-village-lund/
LOCATION:Medicon Village\, Scheelevägen 2\, Lund\, Sweden
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/09/Medicon-Valley-Medtech-Network_ny2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180925
DTEND;VALUE=DATE:20180926
DTSTAMP:20260430T065711
CREATED:20180911T082843Z
LAST-MODIFIED:20180911T083151Z
UID:17510-1537833600-1537919999@senzagen.com
SUMMARY:North American Biocompability Summit\, Minneapolis\, US
DESCRIPTION:SenzaGen is participating at The North American Biocompatibility Summit.\nThe event will provide industry insights and expertise sharing on the biocompatibility of medical devices\, including the latest regulatory updates\, biological evaluation strategies and best practices that lead to successful biocompatibility programs.
URL:https://senzagen.com/event/north-american-biocompability-summit-minneapolis-us/
LOCATION:Minneapolis\, United States
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2018/09/nabs-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180923
DTEND;VALUE=DATE:20180927
DTSTAMP:20260430T065711
CREATED:20180911T082419Z
LAST-MODIFIED:20180927T124556Z
UID:17506-1537660800-1538006399@senzagen.com
SUMMARY:EUSAAT\, Linz\, Austria
DESCRIPTION:EUSAAT\, the European Society for Alternatives to Animal Testing\, is the European 3Rs Society. EUSAAT is actively promoting the protection of experimental animals according to the 3Rs-Principle (refine – reduce – replace).
URL:https://senzagen.com/event/eusaat-linz-austria/
LOCATION:Linz\, Austria
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/05/logo_eusaat_web.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180920
DTEND;VALUE=DATE:20180922
DTSTAMP:20260430T065711
CREATED:20180911T082218Z
LAST-MODIFIED:20180911T083247Z
UID:17503-1537401600-1537574399@senzagen.com
SUMMARY:2nd International Conference on Alternative Methods for Cosmetics\, Beijing\, China
DESCRIPTION:SenzaGen will participate in the 2nd International Conference on Alternative Methods for Cosmetics in Beijing. A two day event organized by National Institutes for Food and Drug Control (NIFDC) \, the most prominent institutes for validation of new in vitro test methods for cosmetics in China.
URL:https://senzagen.com/event/2nd-international-conference-on-alternative-methods-for-cosmetics-beijing-china/
LOCATION:Beijing\, China
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/09/Beijing-conference-poster.jpg
END:VEVENT
END:VCALENDAR